Lantheus Medical Imaging, a provider in diagnostic imaging, has extended its contract with Nordion through 2013, for the continued supply of molybdenum-99 (Mo-99).
Mo-99 is the parent isotope of technetium-99m (Tc-99m), the most widely used medical radioisotope in the world for molecular and nuclear diagnostic imaging procedures and is used in Lantheus’ TechneLite (Technetium Tc99m Generator) generators.
Lantheus Medical Imaging president and CEO Don Kiepert said that the extension of their contract with Nordion is another example of their commitment to ensure that their customers continue to have reliable and secure access to this key medical isotope.
Nordion Sales and Marketing senior vice president Kevin Brooks said that this contract extension with Lantheus reflects Nordion’s ongoing commitment to provide a long-term supply of medical isotopes for our customers and the nuclear medicine community.
"As a leading provider to the medical isotope industry, we remain focused on providing our customers, such as Lantheus, with high quality, reliable and flexible supply to serve the dynamic needs of their customers," Brooks said.